New Zealand markets open in 8 hours 38 minutes

Acorda Therapeutics, Inc. (CDG.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
8.420.00 (0.00%)
As of 03:32PM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
115,664
117,633
118,566
129,071
152,967
-
Cost of revenue
15,756
15,283
30,332
40,787
33,513
-
Gross profit
99,908
102,350
88,234
88,284
119,454
-
Operating expenses
Research development
4,720
5,152
5,804
10,420
23,012
-
Selling general and administrative
95,555
89,698
106,256
124,399
152,576
-
Total operating expenses
123,992
125,614
130,270
165,583
206,351
-
Operating income or loss
-24,084
-23,264
-42,036
-77,299
-86,897
-
Interest expense
32,337
31,533
30,200
30,035
30,574
-
Total other income/expenses net
-248,602
-241,754
35,080
-1,745
8,988
-
Income before tax
-304,440
-296,021
-35,247
-109,074
-107,667
-
Income tax expense
-41,015
-43,167
30,669
-5,120
-8,073
-
Income from continuing operations
-263,425
-252,854
-65,916
-103,954
-99,594
-
Net income
-263,425
-252,854
-65,916
-103,954
-99,594
-
Net income available to common shareholders
-263,425
-252,854
-65,916
-103,954
-99,594
-
Basic EPS
2.61
-
-66.80
-195.80
-246.40
-688.60
Diluted EPS
2.61
-
-66.80
-195.80
-246.40
-688.60
Basic average shares
1,264
-
985.35
531.05
404.2
396.349
Diluted average shares
1,264
-
985.35
531.05
404.2
396.349